These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 22500790)

  • 1. Relationship between pancreatic and/or extrapancreatic lesions and serum IgG and IgG4 levels in IgG4-related diseases.
    Igarashi H; Ito T; Oono T; Nakamura T; Fujimori N; Niina Y; Hijioka M; Uchida M; Lee R; Iwao R; Nakamura K; Kotoh K; Takayanagi R
    J Dig Dis; 2012 May; 13(5):274-9. PubMed ID: 22500790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum IgG4 levels and extrapancreatic lesions in autoimmune pancreatitis.
    Kamisawa T; Imai M; Egawa N; Tsuruta K; Okamoto A
    Eur J Gastroenterol Hepatol; 2008 Dec; 20(12):1167-70. PubMed ID: 18936710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic sclerosing sialadenitis (Küttner tumor) is an IgG4-associated disease.
    Geyer JT; Ferry JA; Harris NL; Stone JH; Zukerberg LR; Lauwers GY; Pilch BZ; Deshpande V
    Am J Surg Pathol; 2010 Feb; 34(2):202-10. PubMed ID: 20061932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum immunoglobulin G4 associated with number and distribution of extrapancreatic lesions in type 1 autoimmune pancreatitis patients.
    Kaji R; Takedatsu H; Okabe Y; Ishida Y; Sugiyama G; Yonemoto K; Mitsuyama K; Tsuruta O; Sata M
    J Gastroenterol Hepatol; 2012 Feb; 27(2):268-72. PubMed ID: 21929654
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lymphadenopathy of IgG4-related sclerosing disease.
    Cheuk W; Yuen HK; Chu SY; Chiu EK; Lam LK; Chan JK
    Am J Surg Pathol; 2008 May; 32(5):671-81. PubMed ID: 18344866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IgG4-related sclerosing disease incorporating sclerosing pancreatitis, cholangitis, sialadenitis and retroperitoneal fibrosis with lymphadenopathy.
    Kamisawa T; Nakajima H; Egawa N; Funata N; Tsuruta K; Okamoto A
    Pancreatology; 2006; 6(1-2):132-7. PubMed ID: 16327291
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoimmune pancreatitis: a systemic immune complex mediated disease.
    Deshpande V; Chicano S; Finkelberg D; Selig MK; Mino-Kenudson M; Brugge WR; Colvin RB; Lauwers GY
    Am J Surg Pathol; 2006 Dec; 30(12):1537-45. PubMed ID: 17122509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IgG4-related sclerosing disease: a critical appraisal of an evolving clinicopathologic entity.
    Cheuk W; Chan JK
    Adv Anat Pathol; 2010 Sep; 17(5):303-32. PubMed ID: 20733352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Roles of IL-17, Th1, and Tc1 cells in patients with IgG4-related sclerosing sialadenitis.
    Ohta N; Makihara S; Okano M; Kurakami K; Ishida A; Furukawa T; Suzuki Y; Watanabe T; Kakehata S; Aoyagi M
    Laryngoscope; 2012 Oct; 122(10):2169-74. PubMed ID: 22786718
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and pathological characteristics of IgG4-related sclerosing sialadenitis.
    Ohta N; Kurakami K; Ishida A; Furukawa T; Saito F; Kakehata S; Izuhara K
    Laryngoscope; 2012 Mar; 122(3):572-7. PubMed ID: 22241660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of immunohistochemistry for IgG4 in the distinction of autoimmune pancreatitis from peritumoral pancreatitis.
    Dhall D; Suriawinata AA; Tang LH; Shia J; Klimstra DS
    Hum Pathol; 2010 May; 41(5):643-52. PubMed ID: 20149413
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [IgG4-related sclerosing disease].
    Kamisawa T; Zenimoto M; Obayashi T
    Rinsho Byori; 2009 Nov; 57(11):1113-9. PubMed ID: 20030180
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunoglobulin G4, autoimmune pancreatitis and pancreatic cancer.
    Bojková M; Dítě P; Dvořáčková J; Novotný I; Floreánová K; Kianička B; Uvírová M; Martínek A
    Dig Dis; 2015; 33(1):86-90. PubMed ID: 25531501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical study of autoimmune pancreatitis using anti-IgG4 antibody and patients' sera.
    Aoki S; Nakazawa T; Ohara H; Sano H; Nakao H; Joh T; Murase T; Eimoto T; Itoh M
    Histopathology; 2005 Aug; 47(2):147-58. PubMed ID: 16045775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunoglobulin G4-related autoimmune pancreatitis and sialadenitis: A case report.
    Fan RY; Sheng JQ
    World J Gastroenterol; 2015 Aug; 21(31):9448-52. PubMed ID: 26309373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IgG4+ to IgG+ plasma cells ratio of ampulla can help differentiate autoimmune pancreatitis from other "mass forming" pancreatic lesions.
    Sepehr A; Mino-Kenudson M; Ogawa F; Brugge WR; Deshpande V; Lauwers GY
    Am J Surg Pathol; 2008 Dec; 32(12):1770-9. PubMed ID: 18779730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevation of serum IgG4 in Western patients with autoimmune sclerosing pancreatocholangitis: a word of caution.
    Hochwald SN; Hemming AW; Draganov P; Vogel SB; Dixon LR; Grobmyer SR
    Ann Surg Oncol; 2008 Apr; 15(4):1147-54. PubMed ID: 18219538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [IgG4-related sclerosing disease, including its relation to carcinogenesis].
    Kamisawa T; Sasaki T
    Gan To Kagaku Ryoho; 2011 Mar; 38(3):347-52. PubMed ID: 21403435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical significance of extrapancreatic lesions in autoimmune pancreatitis.
    Naitoh I; Nakazawa T; Ohara H; Ando T; Hayashi K; Tanaka H; Okumura F; Miyabe K; Yoshida M; Sano H; Takada H; Joh T
    Pancreas; 2010 Jan; 39(1):e1-5. PubMed ID: 19924018
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of inducible costimulator- and interleukin 10-positive regulatory T cells in the development of IgG4-related autoimmune pancreatitis.
    Kusuda T; Uchida K; Miyoshi H; Koyabu M; Satoi S; Takaoka M; Shikata N; Uemura Y; Okazaki K
    Pancreas; 2011 Oct; 40(7):1120-30. PubMed ID: 21926547
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.